Baby born prematurely at 29 wks on examination at 42wks with ROP both eyes shows stage 2 zone 1 ‘plus’ disease, how will u manage the patient?
First, I need to recall the management guidelines for ROP. ROP is a vasoproliferative disorder in preterm infants, and treatment depends on the stage, zone, and plus disease. The International Classification of Retinopathy of Prematurity (ICROP) is key here.
Stage 2 is a demarcation line, and Zone 1 is the most posterior third of the retina. "Plus disease" refers to dilation and tortuosity of the posterior retinal vessels, which is a sign of severe ROP. The management typically involves laser photocoagulation or anti-VEGF agents. For stage 2 zone 1 plus disease, the standard treatment is usually laser therapy, specifically threshold disease as per the guidelines.
Wait, but sometimes anti-VEGF like bevacizumab is used. The choice between laser and anti-VEGF might depend on the center's protocol. However, the core concept here is that threshold disease (which includes stage 2 zone 1 plus) requires immediate treatment to prevent progression to retinal detachment.
Now, the options aren't given, but the correct answer is likely to be "Laser photocoagulation of avascular retina." The other options might include things like observation, anti-VEGF, or other incorrect treatments. The incorrect options would be wrong because observation is too late for threshold disease, and anti-VEGF might not be the first line in some guidelines.
Clinical pearls: Remember that threshold ROP (stage 3 with plus, or stage 2 zone 1 plus) requires immediate treatment. Also, laser is the standard in many cases, but some centers use anti-VEGF. The key is to prevent retinal detachment by treating before it progresses.
**Core Concept**
Retinopathy of Prematurity (ROP) is a vasoproliferative retinal disorder in preterm infants, managed based on the International Classification of ROP (ICROP). Threshold ROP, defined as stage 2 or 3 with plus disease in zone I or II, requires urgent intervention to prevent retinal detachment.
**Why the Correct Answer is Right**
Stage 2 zone I ROP with plus disease is classified as threshold disease per ICROP guidelines. The standard treatment is **laser photocoagulation** of the avascular retina to obliterate the ischemic retina driving neovascularization. This halts progression by reducing the hypoxic stimulus for vascular endothelial growth factor (VEGF) release. Anti-VEGF agents (e.g., bevacizumab) are alternatives but less preferred due to systemic absorption risks and potential need for re-treatment.
**Why Each Wrong Option is Incorrect**
**Option A:** *Observation* is incorrect because threshold ROP requires immediate treatment to prevent retinal detachment.
**Option B:** *Anti-VEGF monotherapy* may regress neovascularization but does not address the underlying avascular retina, risking recurrence.
**Option C:** *Scleral